BRUCE BOOTH

Profile

First Name

: BRUCE

Middle Name

:

Last Name

: BOOTH

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
MIRAGEN THERAPEUTICS INC
BRUCE L BOOTH, BRUCE L. BOOTH, MARVIN CARUTHERS, MARVIN H CARUTHERS, JOHN CREECY, JOHN W. CREECY, THOMAS HUGHES, THOMAS E HUGHES, THOMAS E. HUGHES, KEVIN KOCH, KYLE LEFKOFF, KYLE A. LEFKOFF, JASON LEVERONE, JASON A LEVERONE, ADAM S LEVY, WILLIAM S. MARSHALL, CHRISTOPHER J MORL, JOSHUA RESNICK, DAVID RODMAN, DAVID M. RODMAN, PAUL D. RUBIN
DIRECTOR
AVILA THERAPEUTICS INC
MICHAEL F. BIGHAM, KATRINE BOSLEY, ROY R. LOBB, DANIEL LYNCH, AMIR NASHAT, RAJ PAREKH, VICKI SATO, HENRY SKINNER
DIRECTOR
ZAFGEN, INC.
PETER BARRETT, CAROLE BEN MAIMON, MD, MITCHELL BLOOM, MITCHELL S. BLOOM, MICHAEL CELANO, THOMAS O. DANIEL, ARI GOLDBERG, AVI GOLDBERG, THOMAS HAMILTON, FRANCES HELLER, THOMAS HUGHES, MATTHIAS JAFFE, DENNIS D. KIM, JONATHAN LEFF, DR. LIAM RATCLIFFE, KEVIN STARR, LOU TARTAGLIA, LOUIS TARTAGLIA, FRANK E. THOMAS, JOSEPH TRUITT
DIRECTOR
NIMBUS DISCOVERY, LLC
RAMY FARID, VICKI SATO
DIRECTOR
ON-Q-ITY, INC.
ROBERT S. EPSTEIN, STEPHEN KRAUS, DION MADSEN, SUE SIEGEL, MICHAEL T. STOCUM
DIRECTOR
NUMERATE INC
JOHN GRIFFIN, STEVE HALL, GUIDO LANZA, LUCIO LANZA
DIRECTOR
UNUM THERAPEUTICS, INC.
BEN AUSPITZ, CHRIS CAIN, KAREN FERRANTE, JOHN L. GREEN, PETER HARWIN, ARLENE MORRIS, LIAM RATCLIFFE, MATTHEW ROS, JESSICA SACHS, CHRISTIANA STAMOULIS, CHARLES WILSON
DIRECTOR
LYSOSOMAL THERAPEUTICS, INC.
CORNELIS BEEN, BRUCE L. BOOTH, ROBERT CARPENTER, BERNARD DAVITIAN, DANIEL GEFFKEN, STEVEN HALL, STEVEN E. HALL, DIMITRI KRAINC, CAROLE NEUCHTERLEIN, CAROLE NUECHTERLEIN, HENRI TERMEER, CLAY THORP, PETER WIRTH
DIRECTOR
AVROBIO, INC.
IAN CLARK, PHILLIP B. DONENBERG, KATINA DORTON, DANIEL LOCHNER, GEOFFREY MACKAY, CHRISTOPHER MASON, TERRANCE MCGUIRE, PETER MCNAMARA, CHRISTOPHER PAIGE, DEANNA PETERSEN, ALISE REICIN, SCOTT REQUADT, JOSHUA RESNICK, MARCELLA K. RUDDY, MARC SCHWABISH, TIMOTHY SPRINGER, PRAVEEN P. TIPIRNENI, STEFAN VITOROVIC, KIM WARREN
DIRECTOR
MAGENTA THERAPEUTICS, INC.
JEFFREY ALBERS, MICHAEL BONNEY, ALEXIS BORISY, BLAKE BYERS, THOMAS DANIEL, JOHN DAVIS, JASON GARDNER, AMY RONNEBERG, BASTIANO SANNA, DAVID SCADDEN, ZORAN ZDRAVESKI
EXECUTIVE OFFICER
ATLAS VENTURE FUND XI, L.P.
N/A ATLAS VENTURE ASSOCIATES XI, L.P., N/A ATLAS VENTURE ASSOCIATES XI, LLC, KEVIN BITTERMAN, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES
DIRECTOR
RODIN THERAPEUTICS, INC.
KEES BEEN, ADAM ROSENBERG, SAMANTHA SINGER
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND I, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC, KEVIN BITTERMAN, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES
EXECUTIVE OFFICER
ATLAS VENTURE FUND XII, L.P.
N/A ATLAS VENTURE ASSOCIATES XII, L.P., N/A ATLAS VENTURE ASSOCIATES XII, LLC, KEVIN BITTERMAN, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
DIRECTOR
VIGIL NEUROSCIENCE, INC.
CHERYL BLANCHARD, CHERYL BLANCHARD, PH. D., SUZANNE BRUHN, SHAAN GANDHI, GERHARD KOENIG, IVANA MAGOVCEVIC-LIEBISCH, SPYROS PAPAPETROPOULOS, EVAN THACKABERRY, MARY THISTLE, CLAY THORP, CHRISTOPHER VERNI, STEFAN VITOROVIC, JENNIFER ZIOLKOWSKI
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND II, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLC, KEVIN BITTERMAN, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
EXECUTIVE OFFICER
ATLAS VENTURE FUND XIII, L.P.
N/A ATLAS VENTURE ASSOCIATES XIII, L.P., N/A ATLAS VENTURE ASSOCIATES XIII, LLC, KEVIN BITTERMAN, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
DIRECTOR
MATCHPOINT THERAPEUTICS INC.
DANIEL BECKER, JASON HAFLER, ANDRE TURENNE
EXECUTIVE OFFICER
ATLAS VENTURE FUND XIV, L.P.
N/A ATLAS VENTURE ASSOCIATES XIV, L.P., N/A ATLAS VENTURE ASSOCIATES XIV, LLC, KEVIN BITTERMAN, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY III, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY III, LLC, KEVIN BITTERMAN, MICHAEL GLADSTONE, JASON RHODES
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-04
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2025-08-26 
2024-12-05
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-12-04 
2022-10-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-05 
2022-08-29
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-08-16 
2022-03-03
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-03-02 
2021-10-01
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-09-30 
2021-08-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-13 
2021-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-18 
2020-10-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-18 
2020-06-04
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-05-20 
2019-01-02
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-12-07 
2018-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-04-02 
2018-02-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-19 
2017-09-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-30 
2017-06-30
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-06-28 
2017-05-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-21 
2017-01-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2016-11-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-10 
2016-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-03 
2016-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-21 
2015-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-10 
2015-02-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2015-02-03 
2015-02-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2014-10-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-03 
2014-06-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-10 
2014-06-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-23 
2012-12-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-30 
2012-08-28
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-13 
2012-04-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-10 
2012-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-14 
2012-01-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2010-09-10 
2011-07-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-30 
2011-03-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-28 
2010-09-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2010-09-10 
2010-07-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-16 
2010-04-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-15 
2010-03-02
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-17 
2010-03-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-17 
2009-07-31
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-07-16 
2009-05-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-15 
2009-05-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-05-16